Key result
Home blood pressure monitoring improves diagnostic accuracy in chronic kidney disease and preliminary data suggest it outperforms office monitoring in predicting progression to end-stage renal disease.
Why the study?
Does home blood pressure monitoring improve diagnostic accuracy and blood pressure control in patients with chronic kidney disease?
Does home blood pressure monitoring improve diagnostic accuracy and blood pressure control in patients with chronic kidney disease?
Home blood pressure monitoring is a valuable tool for improving diagnostic accuracy and blood pressure control in patients with chronic kidney disease, who frequently exhibit white coat or masked hypertension.
Answers are grounded in this paper and cite their sources.
May support home BP monitoring for CKD accuracy; leaves open prospective confirmation of ESRD prediction benefit.
Despite the availability of blood pressure (BP)-lowering medications and dietary education, hypertension is still poorly controlled in the chronic kidney disease (CKD) population. As glomerular filtration rate declines, the number of medications required to achieve BP targets increases, which may lead to reduced patient adherence and therapeutic inertia by the clinician. Home BP monitoring (HBPM) has emerged as a means of improving diagnostic accuracy, risk stratification, patient adherence, and therapeutic intervention. The definition of hypertension by HBPM is an average BP >135/85 mm Hg. Twelve readings over the course of 3-5 days are sufficient for clinical decision making. Diagnostic accuracy is especially important in the CKD population as approximately half of these patients have either white coat hypertension or masked hypertension. Preliminary data suggest that HBPM outperforms office BP monitoring in predicting progression to end-stage renal disease or death. When combined with additional support such as telemonitoring, medication titration, or behavioral therapy, HBPM results in a sustained improvement in BP control. HBPM must be adapted to provide information on the phenomena of nondipping (absence of nocturnal fall in BP) and reverse dipping (paradoxical increase in BP at night). These diurnal patterns are more prevalent in the CKD population and are important cardiovascular risk factors. Ambulatory BP monitoring provides nocturnal BP readings and unlike HBPM may be reimbursed by Medicare when certain criteria are met. Further studies are needed to determine whether HBPM is cost-effective in the current US healthcare system.
No takes yet. Share an insight, caveat, or question.
Sanghavi et al. (2014) conducted a review in Chronic Kidney Disease and Hypertension. Home Blood Pressure Monitoring (HBPM) vs. Office Blood Pressure Monitoring was evaluated. Home blood pressure monitoring improves diagnostic accuracy in chronic kidney disease and preliminary data suggest it outperforms office monitoring in predicting progression to end-stage renal disease.
Synapse has enriched 10 related papers. Consider them for comparative context: